The Patent Finder

Aronex Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Aronex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Aronex Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,074,769Oligonucleotide inhibitors of bcl-xL
Lapsed on the fee record
Ended Jul 11, 2010 · From the USPTO record
Lapsed on the fee recordEnded Jul 11, 2010From the USPTO record
US 6,323,185Anti-viral guanosine-rich oligonucleotides and method of treating HIV
Formerly held
Lapsed on the fee record
Ended Nov 27, 2009 · From the USPTO record
Lapsed on the fee recordEnded Nov 27, 2009From the USPTO record
US 6,200,597Formulation and use of carotenoids in treatment of cancer
Lapsed on the fee record
Ended Mar 13, 2009 · From the USPTO record
Lapsed on the fee recordEnded Mar 13, 2009From the USPTO record
US 6,184,369Anti-viral guanosine-rich oligonucleotides
Lapsed on the fee record
Ended Feb 6, 2009 · From the USPTO record
Lapsed on the fee recordEnded Feb 6, 2009From the USPTO record
US 6,150,339Anti-viral guanosine-rich oligonucleotides
Lapsed on the fee record
Ended Nov 21, 2008 · From the USPTO record
Lapsed on the fee recordEnded Nov 21, 2008From the USPTO record
US 6,355,785Guanosine-rich oligonucleotide integrase inhibitors
Lapsed on the fee record
Ended Mar 12, 2006 · From the USPTO record
Lapsed on the fee recordEnded Mar 12, 2006From the USPTO record
US 6,288,042Anti-viral guanosine-rich tetrad forming oligonucleotides
Lapsed on the fee record
Ended Sep 11, 2005 · From the USPTO record
Lapsed on the fee recordEnded Sep 11, 2005From the USPTO record
US 6,069,132Phosphazole compounds
Lapsed on the fee record
Ended May 30, 2004 · From the USPTO record
Lapsed on the fee recordEnded May 30, 2004From the USPTO record
US 5,567,604Anti-viral guanosine-rich oligonucleotides
Term ended
Term ended no later than Oct 22, 2016 · Low confidence
Term endedTerm ended no later than Oct 22, 2016Low confidence
US 5,587,458Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
Term ended
Term ended no later than Dec 24, 2016 · Low confidence
Term endedTerm ended no later than Dec 24, 2016Low confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited